Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookUganda Clinical Guidelines 2003 - National Guidelines on Management of Common Conditions (NDA, WHO; 2003; 523 pages)
View the documentAbbreviations
View the documentUnits of measurement
View the documentForeword
View the documentPreface
View the documentAcknowledgements
View the documentPresentation of information
View the documentReferences
View the documentHow to diagnose & treat in primary care
View the documentCommunication skills in the consultation
View the documentHow to make time for quality care
View the documentEvidence-based guidelines
View the documentChronic care
Open this folder and view contentsPrescribing guidelines
Open this folder and view contents1. Infections
close this folder2. Parasitic diseases
View the document2.1 ASCARIASIS (Roundworm)
View the document2.2 DRACUNCULIASIS (Guinea worm)
View the document2.3 ECHINOCOCCOSIS (Hydatid disease)
View the document2.4 ENTEROBIASIS (Threadworm)
View the document2.5 HOOKWORM
View the document2.6 LEISHMANIASIS
View the document2.7 MALARIA
View the document2.8 ONCHOCERCIASIS (River blindness)
View the document2.9 PEDICULOSIS
View the document2.10 SCHISTOSOMIASIS (Bilharziasis)
View the document2.11 STRONGYLOIDIASIS
View the document2.12 TAENIASIS (Tapeworm infestation)
View the document2.13 TRICHURIASIS (Whipworm infestation)
View the document2.14 HUMAN AFRICAN TRYPANOSOMIASIS (Sleeping sickness)
Open this folder and view contents3. Respiratory diseases
Open this folder and view contents4. Gastrointestinal conditions
Open this folder and view contents5. Injuries and trauma
Open this folder and view contents6. Endocrine system conditions
Open this folder and view contents7. Nutritional and haematologic conditions
Open this folder and view contents8. Cardiovascular diseases
Open this folder and view contents9. Skin diseases
Open this folder and view contents10. Central nervous system / Psychiatric conditions
Open this folder and view contents11. Eye conditions
Open this folder and view contents12. Ear, nose and throat conditions
Open this folder and view contents13. Genito-urinary diseases
Open this folder and view contents14. HIV/AIDS and sexually transmitted infections
Open this folder and view contents15. Obstetric and gynaecological conditions
Open this folder and view contents16. Musculoskeletal conditions and joint diseases
Open this folder and view contents17. Miscellaneous conditions
Open this folder and view contents18. Poisoning
Open this folder and view contents19. Dental and oral conditions
Open this folder and view contents20. Hepatic and biliary diseases
Open this folder and view contents21. Childhood illness
Open this folder and view contents22. Family planning (FP)
View the documentAppendix 1: Anti-TB drug intolerance guidelines
View the documentAppendix 2: HIV/AIDS health worker safety & universal hygiene precautions
View the documentAmendment form
View the documentGlossary
View the documentNotes
 

2.14 HUMAN AFRICAN TRYPANOSOMIASIS (Sleeping sickness)

A disease transmitted to humans by several species of tsetse fly belonging to the genus Glossina

Cause

• Two types of trypanosomes (a protozoa) spread through the bite of tsetse fly:

- Trypanosoma rhodesiense (mostly in the Central and Eastern regions)

- Trypanosoma gambiense (mostly in West Nile region)


Clinical features

• May be history of tsetse fly bite
• May be swelling at site of bite after 7-14 days
• Headache not responding to common analgesics
• Fever
• Lymphadenopathy (generalised)
• Weight loss
• At later stage: sleepiness (T. gambiense)
• Coma and death if not treated


Differential diagnosis

Malaria
• TB
• Meningitis
• AIDS


Investigations

Blood: slides for trypanosomes
CSF: for trypanosomes
Aspirate from chancre or lymph node: for trypanosomes


Management

This is based on the findings of the CSF analysis. To determine the drug of choice, the disease is divided into two stages: early and late stage

Management of early stage

CSF is normal, ie.

• Lymphocytes ≤ 5 cells/cubic millimetre

• Total protein <37mg/dL (by dye-binding protein assay) or <25mg/dL (by Double Standard & Centrifuge Method)

• Absence of trypanosomes (by Double Standard and Centrifuge Method)


Treatment for early stage (see Table 1 over)
HC4

T. rhodesiense:

suramin IV


T. gambiense:

suramin IV


- in onchocerciasis-free areas or pentamidine 4% or 10% IM

- in onchocerciasis-endemic areas or if the drug has not been used locally for prophylaxis


Table 1: Treatment schedule for early stage

T. rhodesiense or T. gambiense (adult 50kg and over)

Day

Suramin IV

Pentamidine 4% IM

Pentamidine 10% IM

0

250mg (test dose)

200mg (5mL)

200mg (2mL)

1

-

200mg

200mg

2

500mg

200mg

200mg

3

Do LP If no trypanosomes give five 1g doses as follows:

200mg

200mg

4

1g

200mg

200mg

5

-

200mg

200mg

6

-

200mg

200mg

10

1g

-

-

16

1g

-

-

22

1g

-

-

28

1g

-

-

Management of late stage (CSF is abnormal)
HC4

- see Table 2 below for detailed dose regime


T. rhodesiense:

day 0 and 2: suramin IV then from day 4:
melasorprol 3.6% IV
plus oral corticosteroids


T. gambiense:

preferably (if available) day 0 and day 2 start with: suramin IV

or (in onchocerciasis-endemic areas):

pentamidine IM (day 0, 1 and 2 - as in Table 1 above)

then from day 4 give:

melarsoprol 3.6% IV

plus oral corticosteroids


Note:

suramin: do not use this drug for early or late-stage T. gambiense treatment in onchocerciasis-endemic areas as it may cause blindness in any onchocerciasis-infected patients by killing the filariae in the eye

- use pentamidine instead


♦ corticosteroids: should be given to patients with late trypanosomiasis on melarsoprol who may have hypoadrenalism - the steroids may also reduce any drug reactions


Prevention

Trapping of tsetse flies

• Clearing of bushes around homes and paths

• Early detection and treatment of cases

• Provision of latrines so that people do not go into the bush where they are likely to come into contact with tsetse flies


_____________________________________________________________________________

Notes for Table 2 (opposite)

Cortisone:

- do not give this after day 24 even though the melarsoprol treatment is not yet complete

- if prednisolone is used instead of this, the anti-inflammatory action is similar but the correction of the hypoadrenalism will be much less marked


Table 2: Treatment schedule for late stage

T. rhodesiense or T. gambiense (adult 50kg and over)

Day

Suramin IV or Melarsoprol 3.6% IV

Cortisone oral

0

suramin 250mg (test dose)

-

1

-

-

2

suramin 500mg

-

3

Do LP If trypanosomes present, on day 4, continue with:

-

4

melasorprol 0.5mL

50mg

5

melarsoprol 1mL

50mg

6

melarsoprol 1.5mL

50mg

7-10

-

50mg

11-13

-

37.5mg

14

melarsoprol 2mL

37.5mg

15

melarsoprol 2.5mL

37.5mg

16

melarsoprol 3mL

37.5mg

17

-

37.5mg

18-22

-

25mg

23

melarsoprol 3.5mL

25mg

24

melarsoprol 4mL

25mg

25-30

-

-

31-33

melarsoprol 5mL

-

Child doses: calculate using body weight as follows:

• suramin: 20mg/kg
• pentamidine: 4mg/kg
• melarsoprol: weight (kg)/60 x adult dose

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French